◆英語タイトル:Interface Biologics Inc - Product Pipeline Analysis, 2017 Update
◆商品コード:DATA8010066
◆発行会社(調査会社):
GlobalData
◆発行日:2017年12月27日
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※
GlobalData社の概要はこちらでご確認いただけます。
【レポートの概要】
Summary
Interface Biologics Inc (IBI) is a developer transformative biomedical polymer technology. The company offers anti-thrombogenic and combination drug delivery devices. Its blood contacting medical devices uses Endexo technology address problems related to thrombosis. IBI’s technologies include endexo, kinesyx and epidel. The company provides combination drug delivery devices which include Epidel and Kinesyx. Its products improve the safety and effectiveness of implantable medical devices. The company develops transformative biomedical polymer technologies that enhance the safety and effectiveness of implantable medical devices. IBI is headquartered in Toronto, Ontario, Canada.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Interface Biologics Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Interface Biologics Inc Company Overview 4
Interface Biologics Inc Company Snapshot 4
Interface Biologics Inc Pipeline Products and Ongoing Clinical Trials Overview 4
Interface Biologics Inc – Pipeline Analysis Overview 7
Interface Biologics Inc – Key Facts 7
Interface Biologics Inc – Major Products and Services 8
Interface Biologics Inc Pipeline Products by Development Stage 9
Interface Biologics Inc Pipeline Products Overview 11
EPICUFF 11
EPICUFF Product Overview 11
EPISCREW – Dental Implant 12
EPISCREW – Dental Implant Product Overview 12
EPISCREW – Orthopedic Fixation Device 13
EPISCREW – Orthopedic Fixation Device Product Overview 13
Interface Biologics Inc – Key Competitors 14
Interface Biologics Inc – Key Employees 15
Interface Biologics Inc – Locations And Subsidiaries 16
Head Office 16
Recent Developments 17
Interface Biologics Inc, Recent Developments 17
Feb 14, 2011: Interface Biologics Appoints Art Rosenthal To Chairman Of Board Of Directors 17
Oct 26, 2010: Interface Biologics Receives ISO 13485:2003 Certification 17
Dec 09, 2008: Interface Appoints President And Board Member 17
Aug 25, 2007: Interface Appoints New Advisory Board Member 18
May 08, 2007: Interface Appoints New Advisory Board Member 18
Appendix 19
Methodology 19
About GlobalData 21
Contact Us 21
Disclaimer 22
List of Tables
Interface Biologics Inc Pipeline Products and Ongoing Clinical Trials Overview 4
Interface Biologics Inc Pipeline Products by Equipment Type 5
Interface Biologics Inc Pipeline Products by Indication 6
Interface Biologics Inc, Key Facts 7
Interface Biologics Inc, Major Products and Services 8
Interface Biologics Inc Number of Pipeline Products by Development Stage 9
Interface Biologics Inc Pipeline Products Summary by Development Stage 10
EPICUFF - Product Status 11
EPICUFF - Product Description 11
EPISCREW - Dental Implant - Product Status 12
EPISCREW - Dental Implant - Product Description 12
EPISCREW - Orthopedic Fixation Device - Product Status 13
EPISCREW - Orthopedic Fixation Device - Product Description 13
Interface Biologics Inc, Key Employees 15
Glossary 20